Doç. Dr. Özgen Ahmet Yıldırım

Clinicopathological Predictors of Pathological Complete Response in HER2-Positive Breast Cancer Treated with Pertuzumab-Based Neoadjuvant Therapy: A Multicenter Real-World Study

Medicina, 2026

DOI 10.3390/medicina62040763 PMID 42075632 Texte intégral en libre accèsSource : ORCID

Level II (IIA/IIB) Lymph Node Evaluation in Head and Neck Cancer: A Retrospective Cohort Study from a Non-Endemic Region

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15031068 PMID 41682748 Texte intégral en libre accèsSource : ORCID

Exploring the impacts of docetaxel and paclitaxel based neoadjuvant therapies on early postoperative complications in HER2-positive breast cancer patients

World journal of surgical oncology, 2026

DOI 10.1186/s12957-026-04434-z PMID 42192428 Texte intégral en libre accèsSource : Europe PMC

Claudin 18.2 Positivity Thresholds and Candidate Populations for Targeted Therapy in Pancreatic Ductal Adenocarcinoma: A Real-World Retrospective Cohort

Cancers, 2026

DOI 10.3390/cancers18172827 PMID 42738347 Texte intégral en libre accèsSource : OpenAlex

Structural Acceleration in Sepsis-Associated Cancer Mortality in an Aging Population: A Nationwide Study in the United States, 1999–2020

SSRN Electronic Journal, 2026

DOI 10.2139/ssrn.6201853 Texte intégral en libre accèsSource : OpenAlex

Hepatocellular carcinoma in Turkey: A nationwide health system database analysis of clinical patterns and survival

Cancer Epidemiology, 2026

DOI 10.1016/j.canep.2026.103255 PMID 42887435 Source : ORCID

The Role of Dominant Lesion Site and SUVmax in the Depth of PSA Response in Metastatic Hormone-Sensitive Prostate Cancer

Biomedicines, 2026

DOI 10.3390/biomedicines14102160 PMID 42939968 Texte intégral en libre accèsSource : ORCID

Proton Pump Inhibitor Use and Survival Outcomes in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Immunotherapy: A Real-World Study

Medicina, 2026

DOI 10.3390/medicina62071413 PMID 42512955 Texte intégral en libre accèsSource : ORCID

Impact of COVID-19 Vaccine Type on the Efficacy and Safety of Nivolumab in Patients With Metastatic Non-small-cell Lung Cancer: A Multicenter Study

In Vivo, 2026

DOI 10.21873/invivo.14401 PMID 42379805 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Hospitalized oncology patients with diarrhea: Clinical outcomes and prognostic factors.

Journal of Clinical Oncology, 2026

DOI 10.1200/jco.2026.44.16_suppl.11136 Source : OpenAlex

Pathologic response in relation to total neoadjuvant therapy sequence, completion, and extra consolidation chemotherapy in locally advanced rectal cancer.

Journal of Clinical Oncology, 2026

DOI 10.1200/jco.2026.44.16_suppl.e15648 Texte intégral en libre accèsSource : OpenAlex

Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications

Mutation research. Fundamental and molecular mechanisms of mutagenesis, 2026

DOI 10.1016/j.mrfmmm.2026.111941 PMID 42322921 Source : OpenAlex

Wearable-derived postdischarge mobility as a digital biomarker for 90-day readmission and mortality in metastatic cancer

Supportive Care in Cancer, 2026

DOI 10.1007/s00520-026-11216-6 PMID 42726154 Source : OpenAlex

Real-world treatment patterns and prognostic indicators in upper tract urothelial carcinoma: A Turkish Oncology Group (TOG) study

European Urology Open Science, 2025

DOI 10.1016/s2666-1683(25)01751-3 Texte intégral en libre accèsSource : OpenAlex

CALLY index as an independent predictor of pathological complete response in HER2-positive breast cancer receiving neoadjuvant therapy

Clinical and Translational Oncology, 2025

DOI 10.1007/s12094-025-04077-8 PMID 41091451 8 citations (Europe PMC) Source : ORCID

The Accuracy and Sensitivity of Delta Neutrophil Index in Malignancy: Diagnostic Study of Different Types

Diagnostics, 2025

DOI 10.3390/diagnostics15243187 PMID 41464189 Texte intégral en libre accèsSource : OpenAlex

A CASE REPORT OF NON-SMALL CELL LUNG CANCER PRESENTED WITH METASTATIC SUBCUTANEOUS NODULE ON BREAST SKIN AND COEXISTING SECOND PRIMARY INVASIVE BREAST CANCER WITHIN THE SAME BREAST

2024

DOI 10.22541/au.172444784.41256739/v1 Texte intégral en libre accèsSource : OpenAlex

Clinicopathological Features and First-Line Treatment Outcomes of Geriatric Patients With Extensive-Stage Small Cell Lung Cancer: A Multicenter Study

Cureus, 2023

DOI 10.7759/cureus.35710 PMID 36875256 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Lorlatinib-Related Vision Loss: Two Cases of Non-Small Cell Lung Cancer with Blindness

Journal of Oncological Sciences, 2023

DOI 10.37047/jos.2022-92714 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Onkolojide Moleküler Hedefli Tedaviler

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1478 Texte intégral en libre accèsSource : OpenAlex

Toraks Tümörleri

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1073 Texte intégral en libre accèsSource : OpenAlex

Evaluation of caregiver burden of cancer patients and impact of this burden on caregiver's quality of life

Journal of Health Sciences and Medicine, 2022

DOI 10.32322/jhsm.1025215 3 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

Pancreatic cancer treatment after FOLFIRINOX: prognostic importance of chemotherapy dose intensity and albumin/globulin ratio in second line

Journal of Health Sciences and Medicine, 2022

DOI 10.32322/jhsm.1011658 Texte intégral en libre accèsSource : ORCID

Evaluation of cancer patients receiving concurrent chemotherapy and antituberculosis treatment: Review and case series of a single-center experience

Journal of Surgery and Medicine, 2022

DOI 10.28982/josam.1015461 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Medical Oncology or Surgical Oncology: Which Branch Should Be Started in Esophageal Cancer Diagnostic Evaluation?

Cureus, 2022

DOI 10.7759/cureus.22286 PMID 35350502 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Roles of metabolic tumor volume and total lesion glycolysis on 18F-FDG PET/CT, CA19-9 levels, and complete blood count parameters in predicting survival in patients with unresectable or metastatic pancreatic cancer.

PubMed, 2022

PMID 35166229 1 citation (OpenAlex) Source : OpenAlex

Prognostic Markers in the Treatment of Abiraterone Acetate + Prednisolone and Enzalutamide in Castration-Resistant Metastatic Prostate Cancer

Eurasian Journal of Medical Investigation, 2022

DOI 10.14744/ejmi.2022.22832 Source : OpenAlex

Gastrointestinal Sistem Tümörleri-2

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1212 Texte intégral en libre accèsSource : OpenAlex

The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features

Postgraduate Medicine, 2021

DOI 10.1080/00325481.2021.1934493 PMID 34030576 2 citations (Europe PMC) Source : ORCID

Nivolumab-Related Dry Mouth and Dry Eye: Cross-Sectional Study

Cancer Investigation, 2021

DOI 10.1080/07357907.2021.1971241 PMID 34415812 4 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Depression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delays

Quality of Life Research, 2021

DOI 10.1007/s11136-021-02795-4 PMID 33635508 38 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Evaluation of caregiver burden, and quality of life in metastatic prostate cancer patients and caregivers; Effects of clinical and socioeconomic factors

2021

DOI 10.21203/rs.3.rs-359207/v1 Texte intégral en libre accèsSource : ORCID

68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT

Annals of Nuclear Medicine, 2021

DOI 10.1007/s12149-021-01616-5 PMID 33934311 162 citations (OpenAlex) Source : OpenAlex

Correlations between whole body volumetric parameters of 68Ga-PSMA PET/CT and biochemical-histopathological parameters in castration-naive and resistant prostate cancer patients

Annals of Nuclear Medicine, 2021

DOI 10.1007/s12149-021-01594-8 PMID 33586097 8 citations (OpenAlex) Source : OpenAlex

Role of 68Ga-PSMA PET/CT parameters in treatment evaluation and survival prediction in prostate cancer patients compared with biochemical response assessment.

PubMed, 2021

DOI 10.1967/s002449912303 PMID 33866336 6 citations (OpenAlex) Source : OpenAlex

Evaluation of caregiver burden and quality of life in metastatic prostate cancer patients; Effects of clinical and socioeconomic factors

Dicle Medical Journal / Dicle Tip Dergisi, 2021

DOI 10.5798/dicletip.1037634 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Multimodality Treatment For Peritoneal Mesothelioma: A Single Center Experience

Acta Oncologica Turcica, 2020

DOI 10.5505/aot.2020.71931 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Short term real world safety data of pertuzumab use in HER2 targeted treatment of metastatic breast cancer

Journal of Oncological Sciences, 2018

DOI 10.1016/j.jons.2017.12.002 2 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID